Item 16. Form 10-K Summary.

5K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		CVS HEALTH CORPORATION
Date:	February 16, 2021	By:	/s/ EVA C. BORATTO
			Eva C. Boratto
			Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title(s)	Date

/s/ FERNANDO AGUIRRE	Director	February 16, 2021
Fernando Aguirre

/s/ C. DAVID BROWN II	Director	February 16, 2021
C. David Brown II

/s/ EVA C. BORATTO	Executive Vice President and Chief Financial	February 16, 2021
Eva C. Boratto	Officer (Principal Financial Officer)

/s/ JAMES D. CLARK	Senior Vice President - Controller and Chief	February 16, 2021
James D. Clark	Accounting Officer (Principal Accounting Officer)

/s/ ALECIA A. DECOUDREAUX	Director	February 16, 2021
Alecia A. DeCoudreaux

/s/ NANCY-ANN M. DEPARLE	Director	February 16, 2021
Nancy-Ann M. DeParle

/s/ DAVID W. DORMAN	Chair of the Board and Director	February 16, 2021
David W. Dorman

/s/ ROGER N. FARAH	Director	February 16, 2021
Roger N. Farah

/s/ ANNE M. FINUCANE	Director	February 16, 2021
Anne M. Finucane

/s/ EDWARD J. LUDWIG	Director	February 16, 2021
Edward J. Ludwig

/s/ KAREN S. LYNCH	President and Chief Executive Officer	February 16, 2021
Karen S. Lynch	(Principal Executive Officer) and Director

/s/ LARRY J. MERLO	Director	February 16, 2021
Larry J. Merlo

/s/ JEAN-PIERRE MILLON	Director	February 16, 2021
Jean-Pierre Millon

/s/ MARY L. SCHAPIRO	Director	February 16, 2021
Mary L. Schapiro

/s/ WILLIAM C. WELDON	Director	February 16, 2021
William C. Weldon

/s/ TONY L. WHITE	Director	February 16, 2021
Tony L. White

Previous: Item 15. Exhibits, Financial Statement Schedules.